ULTRAHDR
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Oct 2024)
What this means for you
This application is over — abandoned 14 Oct 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97272374
- Mark type
- Stylized text
- Filed
- 17 Feb 2022
- Published for opposition
- 10 Jan 2023
- Abandoned
- 14 Oct 2024
- Attorney of record
- Philip R. Zender
Goods and services
- Class 042 — Scientific and technological services: Molecular biology research and development services, namely, performing genomic modifications in human cells to develop therapeutics using tools comprised of molecular biology reagents, consisting primarily of enzymes and nucleic acid molecules; research and development in the field of biotechnology and pharmaceuticals
Owner
- KAMAU THERAPEUTICS, INC., SOUTH SAN FRANCISCO, CA, US
- Graphite Bio, Inc., South San Francisco, CA, US
- Graphite Bio, Inc., South San Francisco, CA, US
Prosecution history
- 14 Oct 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Oct 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Aug 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 05 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Mar 2024 — SOU EXTENSION 2 GRANTED
- 01 Mar 2024 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Aug 2023 — SOU EXTENSION 1 GRANTED
- 24 Aug 2023 — SOU EXTENSION 1 FILED
- 24 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 07 Mar 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Jan 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Jan 2023 — PUBLISHED FOR OPPOSITION
- 21 Dec 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Dec 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER